If you’ve been researching NAD+ supplementation, patches and injections probably caught your attention. They sound more clinical than a powder you stir into water. More direct. More serious.

The appeal makes sense. Both methods promise to bypass digestion and deliver NAD+ straight into your bloodstream. For something as important as cellular energy, that sounds like an upgrade over a capsule.

Here’s what most comparisons leave out: getting NAD+ into your blood is not the same as getting it into your cells. And the research on whether patches or injections accomplish the latter is thinner than most people realize.

CLIA-Certified NAD Blood Test

Test your intracellular NAD+ levels from home.

Why People Turn to NAD Patches and Injections in the First Place

The logic behind both methods is intuitive. Oral supplements have to survive digestion before anything useful reaches your bloodstream. If you can skip that step, you should end up with more NAD+ available for your cells. On paper, patches and injections seem like the smarter route.

It’s a reasonable conclusion. But it rests on an assumption worth examining: that the NAD+ delivered into your blood actually ends up where it needs to go.

This section covers how each method works before we get to what the evidence says about whether either one is doing what people assume.

How NAD+ Patches Work

NAD+ patches are worn on the skin, typically on the upper arm, inner wrist, or abdomen. They release NAD+ gradually through the skin over 12 to 14 hours. Some use passive diffusion, while others use iontophoresis technology, which applies a mild electrical current to push molecules through the skin barrier more actively.

The appeal is convenience. No needles, no clinic visit, no scheduled appointments. You apply the patch and go about your day. Depending on the brand, patches contain anywhere from 400mg to over 1,000mg of NAD+.

How NAD+ Injections Work

NAD+ injections are administered subcutaneously (just beneath the skin into fatty tissue) or intramuscularly. Both routes bypass the digestive system entirely, delivering NAD+ directly into tissue near the bloodstream.

Subcutaneous doses are typically in the 50 to 200mg range, given two to three times per week. Intramuscular injections absorb faster and allow for slightly larger volumes. Most protocols require a clinic visit or physician oversight, though some providers have moved toward at-home self-injection kits. For a complete breakdown of how each injection route works, our overview of NAD+ injections covers the key differences.

The Core Problem Both Methods Share

Before comparing patches to injections against each other, there is a more important question worth answering first: does either method actually raise NAD+ inside your cells?

This is where most comparison articles stop short.

NAD+ Is Too Large to Cross Cell Membranes

NAD+ is an intracellular molecule. It does not naturally circulate in the bloodstream in meaningful amounts, and there is a clear biological reason for that: the NAD+ molecule is too large to cross cell membranes intact.

Dr. Eric Verdin, President of the Buck Institute for Research on Aging, has stated this directly: “NAD+ is too big to enter cells and is mostly broken down into nicotinamide when injected. Oral precursors like NMN or NR are a better bet for most people.”

Research published in Science Advances on NAD+ precursor synthesis pathways confirms that even intravenously administered NAD+ is rapidly broken down into smaller metabolites before reaching intracellular targets. A study in Metabolites examining extracellular NAD+ metabolism in human cells found that dinucleotides and mononucleotides are degraded by blood enzymes to nucleosides before cells can absorb them.

Delivering NAD+ into your bloodstream does not reliably translate into raising NAD+ inside your cells.

What “Bioavailability” Actually Means for NAD+

Most discussions of patches versus injections focus on bioavailability in terms of how much NAD+ reaches your blood. That is the wrong metric.

The relevant target for NAD+ is intracellular concentration, measured in micromoles (μM). According to Dr. Jin-Xiong She, founder of Jinfiniti Precision Medicine and a genomic researcher with over 400 peer-reviewed publications, the optimal intracellular NAD+ range is 40 to 100 μM. Levels below 40 μM are associated with fatigue, slower recovery, and reduced cellular repair capacity. Levels above 100 μM are not associated with additional benefit and may carry risk.

A 2019 pilot study in Frontiers in Aging Neuroscience found that urinary NAD+ levels jumped 538% during a six-hour IV infusion, meaning a substantial portion of what was delivered passed through the body without being used at the cellular level. Raising the number in your blood is not the same as raising it where it does anything useful.

To understand what intracellular NAD+ actually does in the body, starting with the fundamentals of how NAD+ functions at the cellular level gives useful context.

Comparing Patches and Injections Side by Side

With the core limitation in mind, here is how the two methods compare across the factors that matter most.

Both columns share the same most important row: no published randomized controlled trials demonstrating intracellular NAD+ improvement.

The Evidence Gap for NAD+ Patches

The research on NAD+ patches specifically is sparse. As a review by Bolt Pharmacy found, no peer-reviewed human clinical trials have evaluated the efficacy of NAD+ patches, and bioavailability through intact skin remains unestablished. There is no published pharmacokinetic data measuring blood NAD+ levels following patch application, let alone intracellular levels.

The iontophoresis technology used in some patches is legitimate and has real medical applications. Whether it can meaningfully push NAD+ molecules through skin and into cells is a separate question, and it remains unanswered by the published literature.

The Evidence Gap for NAD+ Injections

There is currently no published clinical evidence demonstrating the safety, efficacy, or clinical benefit of NAD+ administered via subcutaneous or intramuscular injection.

Subcutaneous injections typically deliver just 20mg of NAD+ per dose, which is far below even IV infusion doses of 500mg. And the evidence for IV NAD+ therapy itself is extremely limited. If 500mg infused directly into a vein does not reliably raise intracellular levels, the case for 20mg under the skin is difficult to defend on current evidence.

What the Clinical Data Points to Instead

If patches and injections both lack trial evidence for intracellular improvement, what does the research support?

The answer is NAD+ precursors delivered orally, specifically molecules like NMN and nicotinamide riboside (NR) that are small enough to enter cells, or that convert into forms that can.

Why NAD+ Precursors Work Differently

Unlike NAD+ itself, precursor molecules are designed to raise intracellular levels through a different mechanism. NR can cross cell membranes directly and is converted to NAD+ inside the cell. NMN is converted to NR outside the cell first, enters the cell, then reconverts to NMN and ultimately to NAD+. Both pathways have been studied in multiple randomized controlled trials in humans, with consistent findings showing meaningful increases in intracellular NAD+ levels.

This is a fundamentally different approach than delivering NAD+ directly by patch or injection. Precursors give cells the raw materials to build NAD+ from the inside, rather than trying to deliver a molecule that cannot reliably get through the cell membrane in the first place.

The Multi-Pathway Advantage

Formulation quality matters as much as precursor choice. Research comparing single-ingredient NAD+ precursors against multi-pathway formulas shows a meaningful gap in outcomes.

In Jinfiniti’s own clinical trial, 85% of participants reached optimal intracellular NAD+ levels (40–100 μM) within four weeks of supplementing with Vitality NAD+ Booster, a formula combining NMN, niacinamide, creatine monohydrate, and D-Ribose.

NAD+ levels doubled on average across the group. Clinical data from a separate functional medicine clinic comparing patients on subcutaneous NAD+ injections against the Vitality formula found that not a single patient on injections reached the optimal intracellular range, while the majority on the oral formula did.

As Dr. She explains: “The goal isn’t a specific milligram dose. It’s reaching and sustaining the optimal intracellular range of 40 to 100 μM. And the only way to know whether any method is actually getting you there is to measure it.”

How to Know If Any NAD Treatment Is Working

Whether you’re using patches, injections, or an oral formula, symptom tracking has real limits. Energy and cognitive clarity can shift for many reasons that have nothing to do with NAD+. Suboptimal levels can also persist without obvious symptoms.

The honest answer is that intracellular testing is the only reliable way to evaluate whether an intervention is working. You need an actual number in the 40–100 μM range, a baseline to compare against, and a way to confirm whether your approach is moving the needle before committing to a protocol long term.

Jinfiniti’s Intracellular NAD® Test is a CLIA-certified, at-home finger-prick test with results delivered within one week. It is the same test used in the clinical trials referenced above. For guidance on how to interpret results and adjust dosing from there, Jinfiniti’s NAD+ dosage guide walks through the data in plain terms.

RELATED READING

• NAD+ vs Peptides: What Works Better for Cellular Health?
• Urolithin A vs NAD: Which Is Better for Longevity?
• NAD vs Methylene Blue: What the Research Shows

Frequently Asked Questions

Are NAD+ patches FDA-approved?

No. NAD+ patches are sold as supplements, not pharmaceutical products. They have not been approved by the FDA for any therapeutic indication and are not subject to the same evidence requirements as medications. Marketing claims about clinical efficacy should be read with that in mind.

Do NAD+ injections require a prescription?

This depends on the provider and jurisdiction. Some clinics offer NAD+ injections under physician oversight; others operate in less regulated settings. Because there are no established standards for SC or IM NAD+ injection protocols, practices vary widely between providers.

Can you combine patches or injections with oral NAD+ supplements?

Some people do, but there is no clinical evidence guiding combined use. Given that the evidence base for patches and injections is limited, adding them to a proven oral formula does not meaningfully change the picture based on current research. A cleaner starting point is testing your baseline intracellular levels, starting with an evidence-backed formula, and measuring again after four weeks.

How long do NAD+ injection effects last?

Provider marketing often suggests effects lasting several days. There is no published clinical trial data confirming this for subcutaneous or intramuscular NAD+ injections specifically. IV infusions raise circulating NAD+ temporarily, but those effects reflect blood concentration, not verified intracellular improvement.

What side effects are associated with NAD+ patches and injections?

Patches can cause skin irritation, which is more common in people with sensitive skin. Injections may produce redness, tenderness, or discomfort at the injection site. IV infusions carry a more significant profile, including nausea, cramping, chest tightness, and anxiety. These risks are among the reasons leading researchers recommend oral precursors over injectable NAD+.

How do I know if my NAD+ levels are actually low?

Testing is the only reliable way to find out. The optimal intracellular NAD+ range is 40 to 100 μM. Many people fall below this threshold by their 40s or earlier, often without clear symptoms. An at-home intracellular NAD+ test gives you a baseline and a way to track whether any intervention is actually working over time.

Walk into any longevity clinic or scroll through enough biohacking content, and you’ll find NAD+ and peptides listed in the same breath. Sermorelin. BPC-157. GHK-Cu. MOTS-c. NAD+ injections. They appear together on clinic menus, in wellness stacks, on podcasts. The implication is that they’re roughly the same kind of thing and you’re choosing between them.

They’re not the same kind of thing. NAD+ is a molecule your cells use to make energy. It’s inside every cell in your body right now. Peptides are short chains of amino acids that act like biological text messages, sending specific instructions to specific parts of the body. These two things work differently, have different amounts of research behind them, and solve different problems.

Grouping them together causes real confusion about what each does and when, or whether, either is worth pursuing. This article untangles the distinction and walks through six specific comparisons to help you think clearly about each one.

CLIA-Certified NAD Blood Test

Find out if your NAD+ is in the healthy range.

NAD+ Is Not a Peptide

The confusion makes sense. Both NAD+ and peptides come up constantly in anti-aging and longevity conversations, and some clinics sell them side by side. But they are chemically different things that do different jobs.

NAD+ (nicotinamide adenine dinucleotide) is a helper molecule your cells rely on to convert food into usable energy. Think of it as the fuel gauge for your cells. Every cell in your body needs it, all the time, to repair DNA, produce energy, and keep basic functions running. It is not built from amino acids and is not a peptide.

Peptides are different. They’re short chains of amino acids (the same building blocks that make up proteins) that carry targeted instructions. A peptide might tell your pituitary gland to release more growth hormone, or signal skin cells to produce more collagen. The scope is narrow by design. That is both their strength and their limitation.

As Eric Verdin documented in a 2015 review, NAD+ is involved in energy production, DNA repair, and activating proteins called sirtuins (which help regulate how cells age) in virtually every cell in the body. No single peptide does that. Each peptide has one job. NAD+ has hundreds.^[1]

NAD+ also declines with age. By midlife, many adults have 40 to 50% less NAD+ than they did in their 20s. That drop tracks closely with the kind of fatigue, brain fog, and slower recovery that most people write off as just getting older. The good news is that NAD+ levels can be tested and raised.

How Peptides Work and Why the Evidence Varies

The word “peptide” just describes a molecular structure: a short chain of amino acids. It does not tell you what the peptide does. Your body makes thousands of them, and they serve completely different purposes. Insulin is a peptide. So are endorphins. The GLP-1 medications used for weight loss, like Ozempic, are also peptides, and they have some of the most rigorous human research of any drug in recent memory.

The peptides that come up in longevity clinics are a different category. Most of them are experimental. Many are sold as research compounds rather than regulated supplements, and their evidence comes almost entirely from animal studies, not human trials. That does not mean they do nothing. It means we do not yet know what they do in people, at what dose, or over what time frame.

The Regulatory Picture

Not all peptides have the same legal status, and that matters when you’re deciding what to put in your body.

BPC-157 and MOTS-c have both been flagged by the FDA for potential safety concerns, and both appear on WADA’s list of banned substances (the organization that oversees drug testing in competitive sports). This does not automatically make them dangerous. But it is information that most influencers leave out entirely.

NAD+ vs. Specific Peptides: A Side-by-Side Breakdown

Each peptide targets something different. The right question is not which one wins against NAD, but what problem you are actually trying to solve.

Here is an overview before the detailed comparisons:

BPC-157 vs. NAD+

BPC-157 is a synthetic peptide originally derived from a protein found in stomach juice. In animal studies, it has shown the ability to speed up healing in tendons, ligaments, and the gut lining, likely by encouraging the growth of new blood vessels and stimulating the cells that build connective tissue.^[2]

The problem is that those results are almost entirely from animals. There are a handful of small human case reports, but no proper clinical trials. The FDA does not recognize BPC-157 as a legal supplement, and it cannot be sold as one.^[3]

NAD+ does not repair a torn tendon the way BPC-157 is supposed to. What it does is keep the energy supply running in the cells doing the repair work. These are different tools:

• BPC-157 may be worth a conversation with a doctor if you are dealing with a specific injury or chronic gut issues, with realistic expectations about the limited evidence
• NAD+ is the stronger choice for energy, mental clarity, metabolic health, and overall cellular function, with human data to back it up

Sermorelin vs. NAD+

Sermorelin is a synthetic peptide that tells your pituitary gland (a small gland at the base of your brain) to release more growth hormone. Growth hormone naturally declines with age, which can contribute to muscle loss, fat gain, poor sleep, and slower recovery. Sermorelin works by mimicking the body’s own signal for growth hormone release rather than replacing the hormone directly.

The evidence for sermorelin is stronger than for most longevity peptides. Studies on growth hormone restoration in older adults have shown real improvements in muscle mass, body fat, and sleep quality. It requires a prescription and is administered through a compounding pharmacy.^[4]

NAD+ and sermorelin work at different levels of the body:

• Sermorelin works in the hormonal system, addressing growth hormone decline
• NAD+ works inside individual cells, maintaining the energy supply that all hormones and repair processes depend on

Someone with both low and declining growth hormone might benefit from addressing both, but in the right order. They are not alternatives to each other.

GHK-Cu vs. NAD+

GHK-Cu is a small copper-containing peptide that naturally exists in your blood, saliva, and urine. Levels drop significantly as you age, and research has found that this decline is connected to things like thinning skin, slower wound healing, and hair loss. GHK-Cu works by activating the cells that produce collagen and elastin (the proteins that keep skin firm and elastic) and by helping regulate genes involved in tissue repair.

One analysis identified more than 4,000 human genes that GHK-Cu appears to influence. Among the peptides in this article, it has some of the more credible evidence, particularly for skin health.^[5]

GHK-Cu and NAD+ are not competitors:

• GHK-Cu targets structural repair in the skin and connective tissue
• NAD+ targets energy production and cell maintenance across the entire body

Using both makes sense if both goals are relevant. They address different things.

MOTS-c vs. NAD+

MOTS-c is a small peptide produced inside your mitochondria (the parts of your cells that generate energy). Most peptides are encoded in the DNA inside your cell’s nucleus. MOTS-c is unusual because it comes from the DNA inside the mitochondria itself.

A 2015 study in Cell Metabolism found that it plays a role in regulating blood sugar and metabolism, and that it can mimic some of the metabolic benefits of exercise in animal models.^[6]

MOTS-c works inside mitochondria. Mitochondria need NAD+ to function. The two are not alternatives. MOTS-c depends on adequate NAD+ to do its job. Low NAD+ undermines the very system MOTS-c is trying to support.

MOTS-c is also banned by WADA, has no published human clinical trials, and is sold as an unregulated research compound. For anyone interested in metabolic health, building a foundation with NAD+ first is the more sensible and evidence-backed approach.

For more context on how NAD+ compares to other mitochondrial health compounds, see Urolithin A vs. NAD+.

5-Amino-1MQ vs. NAD+

One clarification upfront: 5-amino-1MQ is not a peptide. It is a small synthetic molecule, and it shows up in longevity content because of its relationship to NAD+, not because it belongs in the same category as BPC-157 or sermorelin.

Here is what it does. Your body has an enzyme called NNMT that breaks down a building block your cells use to make NAD+. When NNMT is overactive, your NAD+ gets depleted faster than your body can replenish it. 5-amino-1MQ blocks that enzyme, slowing the breakdown.

In fat cell studies published on PubMed, it raised intracellular NAD+ levels by 1.2 to 1.6 times. Most interest has focused on fat loss and blood sugar regulation.^[7]

There are no published human trials. It is sold as a research compound.

The relationship with NAD+ is synergistic:

• 5-amino-1MQ slows how fast NAD+ gets used up
• NAD+ precursors like NMN and NR increase how much NAD+ your body produces

These two approaches work on the same problem from different angles. Direct NAD+ supplementation has considerably more human research behind it.

Peptide Therapy vs. NAD Injections

Someone comparing peptide therapy to NAD+ injections is usually weighing two clinical options: a full peptide protocol from a longevity or regenerative medicine clinic, versus NAD+ delivered by injection (either directly into a vein or under the skin).

Peptide therapy protocols at clinics typically combine several different peptides at once. A common stack might include one peptide to raise growth hormone, another to help with injury recovery, and another to support skin or collagen. Each peptide delivers a targeted message to one specific system. That specificity is the appeal. But it also means that the protocol as a whole has almost never been studied, and the evidence for each individual component varies from moderate to essentially nonexistent.

NAD+ injections deliver one molecule that every cell in your body uses. The effect is broad rather than targeted. When your NAD+ levels are low, cells across multiple systems are running below capacity. An injection addresses that deficit everywhere at once, not just in one tissue or organ.

Peptide therapy protocols can run several hundred to over a thousand dollars a month depending on what is included. NAD+ injections carry their own clinic-dependent cost. Before committing to either, knowing your baseline NAD+ level tells you whether NAD+ deficiency is part of what you’re dealing with, which changes how any protocol should be sequenced.

For a closer look at what NAD+ injections involve clinically, see NAD injection side effects and what they mean.

How to Choose What to Address First

There is no single right answer, but starting with your goal, then looking at what the evidence actually supports, gets you further than starting with whichever treatment sounds most interesting.

As Dr. Jin-Xiong She, founder of Jinfiniti Precision Medicine, explains: “Most people assume their NAD+ is fine until they test it. The data tells a different story. Intracellular NAD+ is deficient in the majority of adults we see, and that deficiency is affecting energy, recovery, and cellular function in ways they’ve learned to accept as normal aging.”

One thing that separates NAD+ from every peptide on this list: you can measure it. A simple NAD blood test shows your intracellular NAD+ level before you start and again after treatment, so you know whether anything actually changed.

There is no equivalent test for most peptides. You cannot measure whether BPC-157 rebuilt your tendon or whether MOTS-c improved your blood sugar at the cellular level. That difference matters when you are deciding where to put your money and your trust.

Frequently Asked Questions

Is NAD a Peptide?

No. NAD+ is a molecule your cells use to make energy and repair themselves. Peptides are short chains of amino acids that carry targeted signals to specific parts of the body. These are different structures that work in completely different ways. The confusion comes from both being discussed in longevity medicine, not from any real similarity between them.

Can You Take NAD+ and Peptides at the Same Time?

In most cases, yes. NAD+ and the compounds discussed in this article target different systems, so they generally do not interfere with each other. Some of them (MOTS-c, 5-amino-1MQ) actually depend on NAD+ to work properly. That said, any protocol that combines multiple compounds should be supervised by a clinician who can look at your full health picture and flag anything that might interact.

Which Has More Clinical Evidence: NAD+ or Peptide Therapy?

NAD+ has meaningfully more human clinical evidence. Multiple controlled trials in people have looked at NAD+ supplementation, including studies that measured actual intracellular levels before and after. BPC-157 and MOTS-c have almost no human trial data. Sermorelin has more than most, because growth hormone research is more developed. GHK-Cu has moderate evidence, primarily from topical skin studies.

Is 5-Amino-1MQ a Peptide?

No. Despite often being grouped with peptides in longevity content, 5-amino-1MQ is a small synthetic molecule that works by blocking an enzyme that breaks down a building block of NAD+. It is not made of amino acids and does not work the way peptides do.

Do I Need a Prescription for NAD+ Supplementation?

No. NAD+ boosters like NMN and NR are available as supplements without a prescription. NAD+ therapy by injection requires a clinical setting. Most people start with supplements, which have strong clinical trial support and can be taken at home.